Shimeng Wan
Wuhan, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
ADARB1 inhibits glycolysis and progression of cervical cancer through the HMGB1/PFKFB3 axis.
Journal: Biochimica et biophysica acta. Molecular basis of disease
Published: September 15, 2025
PPP1R13L drives cervical cancer progression by suppressing p63-mediated PTEN transcription.
Journal: Cellular and molecular life sciences : CMLS
Published: November 11, 2024
SIX1 enhances aerobic glycolysis and progression in cervical cancer through ENO1.
Journal: Human cell
Published: October 01, 2024
Development and validation of nomograms to forecast overall survival and cancer-specific survival in Asian patients diagnosed with epithelial ovarian cancer.
Journal: Frontiers in surgery
Published: August 24, 2024
Predictive value of the Adult Comorbidity Evaluation 27 on adverse surgical outcomes and survival in elderly with advanced epithelial ovarian cancer undergoing cytoreductive surgery.
Journal: European journal of medical research
Published: April 18, 2023
Multi-omics Analysis Identifies Hypoxia Subtypes and S100A2 as an Immunosuppressive Factor in Cervical Cancer.
Journal: Reproductive sciences (Thousand Oaks, Calif.)
Published: January 10, 2023
TFAP2A promotes cervical cancer via a positive feedback pathway with PD‑L1.
Journal: Oncology reports
Published: December 02, 2022
Showing 1-10 of 10
Last Updated: 09/26/2026